Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

AZLIN

AZLOCILLIN SODIUM

Standard Dose
EQ 2GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AZLIN is listed in Drugs@FDA under application 062417 (ANDA).

Marketing status: Discontinued Active ingredient AZLOCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor BAYER PHARMS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview AZLIN is listed in Drugs@FDA under application 062417 (ANDA). Marketing status: Discontinued Active ingredient AZLOCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor BAYER PHARMS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.